Xiongfei Xu

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Gang Jin · 12 shared papers, 2020–2026 · strength 1.91
   • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
   • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
2. Shiwei Guo · 12 shared papers, 2017–2026 · strength 1.78
   • Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
   • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
   • Paper Cell-free DNA testing for the detection and prognosis prediction of pancreatic cancer. DOI 10.1038/s41467-025-61890-z↗
3. Kailian Zheng · 10 shared papers, 2021–2026 · strength 1.69
   • Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
   • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
4. Xiaoyi Yin · 9 shared papers, 2021–2026 · strength 1.59
   • Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
   • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
5. Suizhi Gao · 10 shared papers, 2020–2026 · strength 1.53
   • Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
   • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
   • Paper Senescence-driven molecular subtyping in pancreatic cancer: a multi-omics framework for precision medicine. DOI 10.1186/s12885-025-15341-z↗
6. Xiaohan Shi · 10 shared papers, 2020–2026 · strength 1.53
   • Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
   • Paper Senescence-driven molecular subtyping in pancreatic cancer: a multi-omics framework for precision medicine. DOI 10.1186/s12885-025-15341-z↗
7. Yunguang Li · 5 shared papers, 2022–2026 · strength 0.86
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
   • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
   • Paper Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients. DOI 10.1172/jci.insight.181873↗
8. Guoxiao Zhang · 5 shared papers, 2021–2025 · strength 0.72
   • Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
   • Paper Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients. DOI 10.1038/s41467-025-57520-3↗
   • Paper Morphomolecular staging to improve stratification of patients with node-negative pancreatic cancer. DOI 10.1093/bjs/znac457↗
9. Lingyu Zhu · 4 shared papers, 2023–2026 · strength 0.71
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
   • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
   • Paper Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients. DOI 10.1172/jci.insight.181873↗
10. Meilong Shi · 3 shared papers, 2026 · strength 0.59
    • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
    • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
    • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
11. Meilong Shi · 3 shared papers, 2025 · strength 0.56
    • Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
    • Paper Senescence-driven molecular subtyping in pancreatic cancer: a multi-omics framework for precision medicine. DOI 10.1186/s12885-025-15341-z↗
    • Paper Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients. DOI 10.1038/s41467-025-57520-3↗
12. Yehan Zhang · 3 shared papers, 2022–2026 · strength 0.51
    • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
    • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
    • Paper Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug… DOI 10.1038/s41467-022-29857-6↗
13. Bin Song · 3 shared papers, 2023–2025 · strength 0.49
    • Paper Senescence-driven molecular subtyping in pancreatic cancer: a multi-omics framework for precision medicine. DOI 10.1186/s12885-025-15341-z↗
    • Paper Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients. DOI 10.1038/s41467-025-57520-3↗
    • Paper Morphomolecular staging to improve stratification of patients with node-negative pancreatic cancer. DOI 10.1093/bjs/znac457↗
14. Dong Gao · 3 shared papers, 2022–2025 · strength 0.47
    • Paper Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients. DOI 10.1172/jci.insight.181873↗
    • Paper Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients. DOI 10.1038/s41467-025-57520-3↗
    • Paper Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug… DOI 10.1038/s41467-022-29857-6↗
15. Bo Li · 4 shared papers, 2020–2023 · strength 0.46
    • Paper Morphomolecular staging to improve stratification of patients with node-negative pancreatic cancer. DOI 10.1093/bjs/znac457↗
    • Paper Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-021-08380-9↗
    • Paper Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC p… DOI 10.1038/s41416-019-0704-2↗
16. Shuo Shen · 4 shared papers, 2020–2023 · strength 0.46
    • Paper Morphomolecular staging to improve stratification of patients with node-negative pancreatic cancer. DOI 10.1093/bjs/znac457↗
    • Paper Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-021-08380-9↗
    • Paper Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC p… DOI 10.1038/s41416-019-0704-2↗
17. Eric Tran · 2 shared papers, 2025–2026 · strength 0.39
    • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
    • Paper Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients. DOI 10.1172/jci.insight.181873↗
18. Zhuo Shao · 3 shared papers, 2020–2023 · strength 0.34
    • Paper Morphomolecular staging to improve stratification of patients with node-negative pancreatic cancer. DOI 10.1093/bjs/znac457↗
    • Paper Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC p… DOI 10.1038/s41416-019-0704-2↗
    • Paper The Landscape of Genetic Alterations Stratified Prognosis in Oriental Pancreatic Cancer Patients. DOI 10.3389/fonc.2021.717989↗
19. Gang Li · 2 shared papers, 2021–2025 · strength 0.26
    • Paper Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients. DOI 10.1038/s41467-025-57520-3↗
    • Paper The Landscape of Genetic Alterations Stratified Prognosis in Oriental Pancreatic Cancer Patients. DOI 10.3389/fonc.2021.717989↗
20. Wei Jing · 2 shared papers, 2021–2025 · strength 0.26
    • Paper Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients. DOI 10.1038/s41467-025-57520-3↗
    • Paper The Landscape of Genetic Alterations Stratified Prognosis in Oriental Pancreatic Cancer Patients. DOI 10.3389/fonc.2021.717989↗
21. Jing Shen · 2 shared papers, 2020–2021 · strength 0.21
    • Paper Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC p… DOI 10.1038/s41416-019-0704-2↗
    • Paper The Landscape of Genetic Alterations Stratified Prognosis in Oriental Pancreatic Cancer Patients. DOI 10.3389/fonc.2021.717989↗
22. Bo Li · 1 shared paper, 2025 · strength 0.20
    • Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
23. Gang Jin · 1 shared paper, 2025 · strength 0.20
    • Paper A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patient… DOI 10.1016/j.tranon.2025.102282↗
24. Huan Wang · 1 shared paper, 2026 · strength 0.20
    • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
25. Huan Wang · 1 shared paper, 2026 · strength 0.20
    • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.